These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


266 related items for PubMed ID: 12576869

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 23. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
    Suh CI, Shanafelt T, May DJ, Shroyer KR, Bobak JB, Crawford ED, Miller GJ, Markham N, Glode LM.
    Mol Cell Probes; 2000 Aug 20; 14(4):211-7. PubMed ID: 10970725
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG.
    J Cell Biochem; 2004 Feb 15; 91(3):540-52. PubMed ID: 14755684
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M.
    Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Clin Cancer Res; 2004 Dec 15; 10(24):8472-8. PubMed ID: 15623627
    [Abstract] [Full Text] [Related]

  • 34. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A.
    Urology; 2008 Jan 15; 71(1):161-7. PubMed ID: 18242387
    [Abstract] [Full Text] [Related]

  • 35. Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies.
    Troyer DA, Lucia MS, de Bruïne AP, Mendez-Meza R, Baldewijns MM, Dunscomb N, Van Engeland M, McAskill T, Bierau K, Louwagie J, Bigley JW.
    Cancer Epidemiol Biomarkers Prev; 2009 Oct 15; 18(10):2717-22. PubMed ID: 19755651
    [Abstract] [Full Text] [Related]

  • 36. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
    Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ.
    Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822
    [Abstract] [Full Text] [Related]

  • 37. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O.
    Clin Cancer Res; 2007 Mar 15; 13(6):1720-5. PubMed ID: 17363525
    [Abstract] [Full Text] [Related]

  • 38. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
    Vidanes GM, Paton V, Wallen E, Peehl DM, Navone N, Brooks JD.
    Prostate; 2002 Jun 01; 51(4):225-30. PubMed ID: 11987150
    [Abstract] [Full Text] [Related]

  • 39. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G, Barker MA, Kaur P, Groshen S, Jones LW, Imam SA, Boyd VL.
    Anal Biochem; 2009 Sep 15; 392(2):117-25. PubMed ID: 19505431
    [Abstract] [Full Text] [Related]

  • 40. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R, Ferdinand L, Reis IM, Schlesselman JJ.
    Oncol Rep; 2004 Sep 15; 12(3):631-7. PubMed ID: 15289848
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.